Industry News
Pharmaceutical Industry News
Amid a rise in misinformation and…
Amid a rise in misinformation and pseudoscientific beliefs, a new corporate push from Bayer seeks to remind Americans of the power of actual science.
MAHA Threatens My Life. I Understand Its Appeal.
The Trump administration has undermined the once bipartisan war on cancer and declined to approve a promising melanoma therapy.
Some three months after merging,…
Some three months after merging, drugmakers Mallinckrodt and Endo have successfully spun off their combined sterile injectables and generics businesses. With the transformation complete, the new generics entity will operate under the moniker Par Health,
Trump Pardons the Husband of a Republican Congressional Ally
Robert Harshbarger Jr. pleaded guilty in 2013 to health care fraud and distributing a misbranded drug. His wife, Diana Harshbarger, is a member of Congress.
What Is Kennedy’s Problem With Medication?
Shaming people for being on medication is dangerous.
La búsqueda de China de conquistar el envejecimiento
Los laboratorios de longevidad, las “islas de la inmortalidad” y pastillas de semillas de uva forman parte del proyecto chino para vencer al envejecimiento.
Like with the August cuts, the…
Like with the August cuts, the latest round of layoffs will mostly affect the team based in Harmans, Maryland.
The action, announced Monday,…
The action, announced Monday, follows a comprehensive review of scientific literature by an expert panel at the agency in July, as well as a public comment period, officials said. Pharmas are expected to update and
Just five months after Novo…
Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered with Emcure Pharmaceuticals to increase access to the weight-loss treatment in the nation, which has a growing obesity problem.
A recently launched campaign…
A recently launched campaign starring patients and scientists shows Sanofi in hot pursuit of scientific innovation.
BridgeBio Pharma has declined to…
BridgeBio Pharma has declined to participate in the National Advertising Division’s investigation into complaints made by Pfizer, leading the self-regulatory body to refer the case to federal agencies.
Merck PCSK9 Pill Results Point to Extremely Low Cholesterol Future
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease risk.
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.
Inside China’s Quest to Defy Aging with Longevity Labs and ‘Immortality Islands’
Longevity labs, “immortality islands” and grapeseed pills are part of China’s national project to conquer aging, despite sometimes shaky science and extravagant claims.
Patient advocacy communities such…
Patient advocacy communities such as Johnson & Johnson's IBD Social Circle can quell the feelings of loneliness and isolation common in those with IBD, the company explains in a new report.
A new TV spot from Bristol Myers…
A new TV spot from Bristol Myers Squibb that debuted Monday morning and will continue airing throughout the week visualizes a world in which healthcare professionals are showered in all the appreciation they’re due.
Gilead revealed that Trodelvy has…
Gilead revealed that Trodelvy has come up short as a first-line treatment for patients with HR+/HER2-negative metastatic breast cancer. The company said that the phase 3 Ascent-07 study comparing Trodelvy to chemotherapy failed to meet
After spending much of the year…
After spending much of the year sloping steadily downward from a January peak, TV drug ad spending picked up in a major way last month.
At the American College of…
At the American College of Allergy, Asthma and Immunology’s annual meeting this week, two drug juggernauts showcased promising data on their respective anti-inflammatory blockbusters, bolstering approval ambitions at the FDA.
They Can’t Stand Trump. But His I.V.F. Policy Might Help Them Have Children.
Even those opposed to President Trump were encouraged by his announcement of a discount on I.V.F. drugs, a policy that followed months of complex negotiations.